Arkolith/Insider Trading/PRME/Form 4

Reine Allan

Chief Executive Officer, DirectorPrime Medicine, Inc. (PRME) · full profile →Form 4 · filed May 22, 2025
Net Buying
Open-Market Buys
$148K
Open-Market Sells
$0
Net Open-Market Flow
$148K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 21, 2025Buy(P)125K$1.18$148K125K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001894562-25-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML